Pulmonary hypertension (PH) is one of the highest risk medical conditions in pregnancy.
Mortality due to PH has been increasing in the United States (5.5/100,000 in 2001 to …

Pulmonary hypertension (PH) may present initially during pregnancy or may be identified in
women contemplating becoming pregnant. Women with idiopathic pulmonary arterial …

Maternal mortality historically has been reported to be as high as 9% to 50% 1–4 in women
with pulmonary hypertension (PH). This mortality increase is thought to be related to the …

Pulmonary hypertension (PH) disproportionately affects women, presenting challenges
during pregnancy. Historically, patients with PH are advised to avoid pregnancy; however …

The anatomic and physiologic changes that occur during pregnancy involve multiple organs
that facilitate fetal development. It is important that pulmonary hypertension (PH) providers …

Background Pregnant women with pulmonary hypertension (PH) are at risk for adverse
cardiac outcomes, particularly at the time of labor and delivery. The purpose of this study is …

(1) Background: In pulmonary arterial hypertension (PAH), pregnancy is regarded a
contraindication due to high maternal and fetal morbidity and mortality. We report our …

Background: Pulmonary hypertension (PH) is a life-threatening disease with significant
maternal morbidity and mortality. Methods: To assess pregnancy and neonatal outcomes …

Pulmonary arterial hypertension (PAH) is a rare and devastating disease characterized by
progressive increases in pulmonary arterial pressure and pulmonary vascular resistance …

Background Pulmonary hypertension (PH) due to left heart disease (World Health
Organization (WHO) Group 2 PH) is the largest PH subgroup, however most reports of PH in …